Are patients' judgments of health status really different from the general population?

by Ruers Theo JM, Tromp Noor, Krabbe Paul FM, van Riel Piet LCM
Published 2011-05-01

Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data

by Beretta Lorenzo, Santaniello Alessandro, van Riel Piet LCM, Coenen Marieke JH, Scorza Raffaella
Published 2010-08-01

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an o...

by van der Maas Aatke, van den Bemt Bart JF, Wolbink Gertjan, van den Hoogen Frank HJ, van Riel Piet LCM, den Broeder Alfons A
Published 2012-09-01

Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study

by van Riel Piet LCM, Hekster Yechiel A, Wolbink GJ, den Broeder Alfons A, van den Bemt Bart JF, Benraad Bart, van den Hoogen Frank HJ
Published 2011-01-01

Macrophage dysfunction in Psoriatic Arthritis

by Wenink Mark H, Santegoets Kim CM, van Bon Lenny, Butcher John, van den Berg Wim B, van Riel Piet LCM, McInnes Iain B, Radstake Timothy RDJ
Published 2011-11-01

Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, Toll-like receptors and rheumatoid synovial fluid

by Schreurs B Willem, Roelofs Mieke F, le Blanc Linda MP, van der Voort Robbert, van Lieshout Antoine WT, van Riel Piet LCM, Adema Gosse J, Radstake Timothy RDJ
Published 2006-09-01